RxDoctor Payments Data

Frederick Lopatin, DO

Otolaryngology · Dearborn, MINPI 1659341691

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (41.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Acclarent, Inc at 29.8% of the total. Reporting peaked in 2022 at $8,803 and has fallen 78.9% since, to $1,857 in 2025. Among otolaryngology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,387in general payments, 2019–2025

Across 336 payments — averaging $72.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$7K
  • Aerin Medical Inc.$4K
  • Stryker$3K
  • Intersect ENT, Inc.$3K
  • Integra Lifesciences Corporation$2K
  • Acelrx Pharmaceuticals, Inc.$2K
  • plus $3K from 15 others
$44,630in research payments, 2019–2025

Across 10 payments — averaging $4463.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$45K

What the payments were for

  • Consulting fees$9,30038%
  • Speaking & faculty fees$7503%
  • Travel & lodging$4,12917%
  • Food & beverage$10,20042%
  • Gifts$80%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,387 in reported general payments places this provider in the 90th percentile of 257 otolaryngology providers in Michigan.

See all otolaryngology providers in Michigan

Medicare billing

Part B allowed, 2024
$353,032
Medicare patients
319
Services billed
1,226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl395$16,189
Fluticasone Propionate488$10,263
Ipratropium Bromide95$3,211
Mometasone Furoate183$2,814
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth20$2,764
Sucralfate45$2,345
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav137$1,334
Mupirocin155$982
Methylprednisolone35$219
Famotidine27$154
Omeprazole15$140
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$67
Acetaminophen-CodeineAcetaminophen With Codeine15$59

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Dearborn

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →